# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025, Regulation 8: Amendment of regulation 56 in relation to England, Scotland and Wales


In regulation 56 (fees payable in relation to clinical investigation notices)—
(a) in paragraph (1)—
(i) in sub-paragraph (a)(i), for “£5,711” substitute “£11,701”;
(ii) in sub-paragraph (a)(ii), for “£11,069” substitute “£22,678”;
(iii) in sub-paragraph (b)(i), for “£7,472” substitute “£15,309”;
(iv) in sub-paragraph (b)(ii), for “£15,627” substitute “£32,016”;
(b) in paragraph (3A)—
(i) in sub-paragraph (a), for “£207” substitute “£226”;
(ii) in sub-paragraph (b), for “£331” substitute “£361”;
(c) in paragraph (3B)—
(i) in sub-paragraph (a), for “£906” substitute “£987”;
(ii) in sub-paragraph (b), for “£782” substitute “£852”.

---
Source: https://www.legislation.gov.uk/uksi/2025/749/regulation/8 (the official version)
Page: https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/regulation-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

